View Clinical Trial (Medical Research Study)

Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy - NCT01053559-32789(Clinical Trial 479059)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Winter Park
State:  
FL
Zip Code: 32789
Conditions: Crohn's Disease
Purpose: Wireless Capsule Endoscopy has been the most reliable diagnostic standard for small bowel Crohn's disease. Endoscopic healing is an important endpoint to measure response to treatment.
Study summary:
Criteria: Inclusion Criteria: - Adults aged 18-70 with confirmed Crohn's disease that includes small bowel disease - Moderately to severely active disease (CDAI score >220 and < 450 - Stable doses of steroids, 5 ASA, antibiotics, Immunosuppressants Exclusion Criteria: - Any and all contraindications to the use of certolizumab pegol (including but not limited to hepatitis, infection, abscess, malignancy, CHF, cytopenia) - Small bowel obstruction, stricture, or any contraindication for capsule endoscopy - Previous treatment with certolizumab pegol - Are pregnant or lactating
Study is available at: Shafran Gastroenterology Center
Winter Park, FL 32789
United States

Primary Contact:
Peggy A Galvis, RN
Email: peggaL7@aol.com
Phone: 4076298121
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.